The global pharmaceutical industry, valued at $1.57 trillion, plays a crucial role in ensuring healthcare access across the world. A significant portion of this market—30% of total revenue—is driven by pharmaceutical tenders, where international agencies procure medicines for low-income countries. However, recent geopolitical shifts, particularly U.S. funding cuts to global health programs, have sent shockwaves through the industry.